PLK1 and neoplasm: Since PLK1 inhibition was shown to promote APC activation in vivo, and bioinformatic analysis exhibited that antigen processing and presentation pathway was enriched in tumor tissues with low PLK1 expression, we were led to hypothesize that the activation of antitumor immunity by PLK1 blockade might be achieved through its modulation on DC function.